Related Experiment Video
Updated: Sep 24, 2026
07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Pediatric hepatobiliary disease
The Surgical Clinics of North America
|October 1, 1985
Insights
This review covers surgical challenges in pediatric hepatobiliary diseases, including biliary atresia, choledochal cysts, gallbladder issues, and liver abscesses in children.
Area of Science:
- Pediatric Surgery
- Hepatology
- Gastroenterology
Background:
- Pediatric hepatobiliary diseases present unique diagnostic and treatment challenges.
- Surgical management is crucial for various conditions affecting the liver, bile ducts, and gallbladder in young patients.
Purpose of the Study:
- To provide an overview of the surgical aspects of common pediatric hepatobiliary diseases.
- To highlight key diagnostic and treatment considerations for these conditions in infants, children, and adolescents.
Main Methods:
- Literature review focusing on surgical management of pediatric hepatobiliary conditions.
- Discussion of diagnostic features and therapeutic strategies for specific diseases.
Main Results:
- Biliary atresia requires timely surgical intervention for potential liver transplant salvage.
- Choledochal cysts necessitate surgical excision to prevent complications like malignancy and biliary obstruction.
- Gallbladder disease and liver abscesses in children have distinct surgical approaches and outcomes.
Conclusions:
- Effective surgical management of pediatric hepatobiliary diseases requires specialized knowledge and timely intervention.
- Early diagnosis and appropriate surgical treatment are critical for improving outcomes in affected children.
Abstract:
The surgical aspects of pediatric hepatobiliary disease concern a unique set of diagnoses, disease processes, diagnostic issues, and treatment problems. In this context, this article discusses features of biliary atresia, choledochal cyst, gallbladder disease, and liver abscess in the infant, child, and adolescent.
More Related Videos
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...